v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Preferred stock
Common stock
Additional paid-in capital
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024   3,985,002      
Balance, beginning of period at Dec. 31, 2024 $ (25,894) $ 0 $ 3 $ 253,652 $ (279,549)
Balances, beginning of period (in shares) at Dec. 31, 2024     31,279,264    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (10,375)       (10,375)
Exercise of options and vesting of restricted stock units (in shares) [1]     159,699    
Exercise of options and vesting of restricted stock units [1] 279     279  
Issuance of common stock through employee stock purchase plan (in shares) [1]     55,670    
Issuance of common stock through employee stock purchase plan [1] 0        
Stock-based compensation 1,620     1,620  
Preferred stock conversion (in shares)   365,000 777,829    
Ending balance (in shares) at Mar. 31, 2025   3,620,002      
Balance, end of period at Mar. 31, 2025 (34,370) $ 0 $ 3 255,551 (289,924)
Balances, end of period (in shares) at Mar. 31, 2025     32,272,462    
Beginning balance (in shares) at Dec. 31, 2024   3,985,002      
Balance, beginning of period at Dec. 31, 2024 (25,894) $ 0 $ 3 253,652 (279,549)
Balances, beginning of period (in shares) at Dec. 31, 2024     31,279,264    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (18,663)        
Ending balance (in shares) at Jun. 30, 2025   3,594,002      
Balance, end of period at Jun. 30, 2025 (19,423) $ 0 $ 3 278,786 (298,212)
Balances, end of period (in shares) at Jun. 30, 2025     37,983,259    
Beginning balance (in shares) at Mar. 31, 2025   3,620,002      
Balance, beginning of period at Mar. 31, 2025 (34,370) $ 0 $ 3 255,551 (289,924)
Balances, beginning of period (in shares) at Mar. 31, 2025     32,272,462    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (8,288)       (8,288)
Exercise of options and vesting of restricted stock units (in shares) [1]     155,051    
Exercise of options and vesting of restricted stock units [1] 56     56  
Issuance of common stock through employee stock purchase plan (in shares) [1]     0    
Issuance of common stock through employee stock purchase plan [1] 211     211  
Stock-based compensation [2] 2,517     2,517  
Proceeds from the issuance of common stock, net of issuance costs (in shares)     5,500,000    
Proceeds from the issuance of common stock, net of issuance costs 20,451     20,451  
Preferred stock conversion (in shares)   26,000 55,746    
Ending balance (in shares) at Jun. 30, 2025   3,594,002      
Balance, end of period at Jun. 30, 2025 $ (19,423) $ 0 $ 3 278,786 (298,212)
Balances, end of period (in shares) at Jun. 30, 2025     37,983,259    
Beginning balance (in shares) at Dec. 31, 2025 0 0      
Balance, beginning of period at Dec. 31, 2025 $ (33,861) $ 0 $ 4 296,718 (330,583)
Balances, beginning of period (in shares) at Dec. 31, 2025 49,997,836   49,997,836    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ 1,539       1,539
Exercise of options and vesting of restricted stock units (in shares) [3]     152,877    
Exercise of options and vesting of restricted stock units [3] 32     32  
Issuance of common stock through employee stock purchase plan (in shares) [3]     44,127    
Issuance of common stock through employee stock purchase plan [3] 0        
Stock-based compensation 2,472     2,472  
Proceeds from the issuance of common stock, net of issuance costs (in shares)     11,219,515    
Proceeds from the issuance of common stock, net of issuance costs 42,625   $ 1 42,624  
Ending balance (in shares) at Mar. 31, 2026   0      
Balance, end of period at Mar. 31, 2026 $ 12,807 $ 0 $ 5 341,846 (329,044)
Balances, end of period (in shares) at Mar. 31, 2026     61,414,355    
Beginning balance (in shares) at Dec. 31, 2025 0 0      
Balance, beginning of period at Dec. 31, 2025 $ (33,861) $ 0 $ 4 296,718 (330,583)
Balances, beginning of period (in shares) at Dec. 31, 2025 49,997,836   49,997,836    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ (7,648)        
Ending balance (in shares) at Jun. 30, 2026 0 0      
Balance, end of period at Jun. 30, 2026 $ 6,550 $ 0 $ 5 344,776 (338,231)
Balances, end of period (in shares) at Jun. 30, 2026 61,469,572   61,469,572    
Beginning balance (in shares) at Mar. 31, 2026   0      
Balance, beginning of period at Mar. 31, 2026 $ 12,807 $ 0 $ 5 341,846 (329,044)
Balances, beginning of period (in shares) at Mar. 31, 2026     61,414,355    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (9,187)       (9,187)
Exercise of options and vesting of restricted stock units (in shares) [3]     55,217    
Exercise of options and vesting of restricted stock units [3] 17     17  
Issuance of common stock through employee stock purchase plan [3] 270     270  
Stock-based compensation 2,616     2,616  
Short-swing profit settlement $ 27     27  
Ending balance (in shares) at Jun. 30, 2026 0 0      
Balance, end of period at Jun. 30, 2026 $ 6,550 $ 0 $ 5 $ 344,776 $ (338,231)
Balances, end of period (in shares) at Jun. 30, 2026 61,469,572   61,469,572    
[1]
(1) The Company records the issuance of the shares when they are recorded by the transfer agent and as such, there could be timing differences between when the expense is recorded and shares are transferred.
[2]
(2) Amount includes $0.6 million related to 2024 bonus paid in 2025 in the form of stock-based compensation.
[3]
(1) The Company records the issuance of the shares when they are recorded by the transfer agent and as such, there could be timing differences between when the expense is recorded and shares are transferred.